Fourth, stringent inclusion/exclusion criteria (e.g., inclusion of AQP4-IgG seropositive patients, exclusion of those with comorbid autoimmune disorders and use of lipid-lowering agents) resulted in a relatively small sample size, diminishing statistical power. This evidence concerns the gene AQP4 and autoimmune disease.